Zaki, Omar A.
Narayan, Raja R.
Srouji, Rami
Boerner, Thomas
Seier, Kenneth
Gönen, Mithat
Connell, Louise C.
Cercek, Andrea
Kemeny, Nancy E.
Balachandran, Vinod P.
Drebin, Jeffrey A.
Soares, Kevin C.
Kingham, T. Peter
Wei, Alice C.
Jarnagin, William R.
D’Angelica, Michael I.
Article History
First Online: 10 November 2025
Disclosure
: This work was supported in part by the NIH/NCI P30 CA008748 Cancer Center Support Grant. L.C.C. has a consulting role with Intera Oncology. A.C. has a consulting role with Amgen, Agenus, Abbvie, Janssen, Roche, Regeneron, Daiichi, Saynko, Pfizer, Merck, GSK, and Summit; and receives research grant funding from GSK and Pfizer. J.A.D. has stocks in IONIS Pharmaceuticals and ALNYLAM Pharmaceuticals. A.C.W. receives research grant funding from Ipsen and is a DSMB member of Histosonics. T.B. is a current employee of Boehringer Ingelheim International GmbH, but this has no relationship with the submitted work.